Sign up
Pharma Capital

Angela Harmantas

Senior Journalist

Angela Harmantas is a senior financial journalist with Proactive Investors. She has nearly ten years' experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. She currently resides in Toronto.

1553005391_Angela2.jpg


© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.